Experience

Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp.

August 18, 2021

Cooley advised Core Scientific, a carbon-neutral vertically integrated blockchain infrastructure and mining company, on its merger agreement with special purpose acquisition company (SPAC) Power & Digital Infrastructure Acquisition Corp. The transaction values the combined company, which will be called Core Scientific Inc. and listed on the Nasdaq, at an implied pro forma fully diluted enterprise value of approximately $4.3 billion. Partners Daniel Peale, David Silverman and Nicolas Dumont led the Cooley team advising Core Scientific.

Read more

Related contacts

Daniel Peale
Partner, Washington, DC
David Silverman
Partner, New York
Richard G.S. Lee
Associate, Washington, DC
Eileen Marshall
Partner, Washington, DC
David Safren
Associate, New York
Pengli Li
Associate, Boston
Todd Gluth
Partner, San Diego
Howard Morse
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Nancy Wojtas
Senior Counsel, Palo Alto
David Walsh
Partner, Reston
Calvin Lee
Associate, New York
Christian Lee
Associate, San Francisco

Related Practices & Industries

Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II

August 4, 2021

Cooley advised FinAccel, the parent of artificial intelligence-enabled digital consumer credit platform Kredivo, on its agreement to merge with VPC Impact Acquisition Holdings II (VPCB), a special purpose acquisition company (SPAC) sponsored by Victory Park Capital (VPC), which will result in Kredivo becoming a publicly traded company on Nasdaq. Partners Ferish Patel, Matthew Bartus, Rama Padmanabhan and Will Cai led the Cooley team advising FinAccel on the transaction, which marks the largest fintech deSPAC transaction in Asia.

Read more

Related contacts

Ferish Patel
Partner, Singapore
Matthew Bartus
Partner, San Francisco
Rama Padmanabhan
Partner, San Diego
Will Cai
Partner, Hong Kong
Rajdeep Roger Bains
Associate, San Diego
Rishab Kumar
Partner, Palo Alto
Xinwei Li
Associate, Singapore
Xander Lee
Partner, Santa Monica
Rick Jantz
Associate, Santa Monica
Aaron Pomeroy
Partner, Colorado
Stella Sarma
Special Counsel, Brussels
Steve Tonsfeldt
Partner, Palo Alto
Nicola Squire
Partner, London
Allison Kutner
Associate, New York
Andrew Epstein
Special Counsel, Seattle
David Peinsipp
Partner, San Francisco
Jie Zhang
Partner, Hong Kong
Paula Holland
Partner, London
Charles Haley
Partner, Palo Alto
Joshua Mates
Partner, San Francisco
Barbara Mirza
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
David Navetta
Partner, Colorado
Ann Bevitt
Partner, London
Calvin Lee
Associate, New York

Related Practices & Industries

Keymed Biosciences – HK$3.1 Billion IPO

July 8, 2021

Cooley advised biotechnology company Keymed Biosciences on its HK$3.1 billion (US$400 million) initial public offering on the Hong Kong Stock Exchange. Partners Yiming Liu, Michael Yu and Will Cai led the Cooley team advising Keymed Biosciences on its public debut, which also included Yiying Wang, Xiaoyu Xu, Kaiting Yang, Henry Wang, Bridget Wang and Iris Yang.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Will Cai
Partner, Hong Kong
Yiying Wang
Associate, Shanghai
Xiaoyu Xu
Associate, Beijing
Kaiting Yang
Associate, Hong Kong
Calvin Lee
Associate, New York
Xander Lee
Partner, Santa Monica

Related Practices & Industries

SPAC BowX Agrees to $9 Billion Merger With WeWork

March 30, 2021

Cooley advised BowX Acquisition Corp., a publicly traded special purpose acquisition company or SPAC, on its agreement to merge with WeWork for $9 billion – a combination that will result in WeWork becoming a publicly listed company. Lawyers Dave Peinsipp, Jamie Leigh, Kevin Cooper, Garth Osterman, Eric Blanchard, Richard Segal, Sangitha Palaniappa and Natasha Patel led the team advising BowX on the transaction, which is expected to close in Q3.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Jamie Leigh
Partner, San Francisco
Kevin Cooper
Partner, New York
Garth Angelo Osterman
Partner, San Francisco
Eric Blanchard
Partner, Boston
Richard Segal
Partner, New York
Sangitha Palaniappa
Associate, Palo Alto
Anna Anderson
Paralegal Specialist, London
Rachel Boyce
Associate, San Francisco
Julia R. Brinton
Associate, Washington, DC
Jacquelyn Burke
Special Counsel, Boston
Caitlin Courtney
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Joshua Elefant
Associate, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stephanie Gentile
Partner, New York
Patrick Gibbs
Partner, Palo Alto
TJ Graham
Partner, Palo Alto
Daniel Han
Associate, New York
Christopher Hutter
Partner, Reston
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Drue Anne Koons
Paralegal Specialist, San Diego
Allison Kutner
Associate, New York
Calvin Lee
Associate, New York
Evan Leitner
Associate, New York
Sarah Lightdale
Partner, New York
Douglas Lyles
Senior Research Services & Access Analyst
Shannon MacMichael
Special Counsel, Washington, DC
Eileen Marshall
Partner, Washington, DC
Margie Murphy
Paralegal Specialist, New York
Howard Morse
Partner, Washington, DC
Pat O'Connell
Associate, New York
Sarah Oliai
Associate, Washington, DC
Liz Paisner
Associate, New York
Amis Pan
Associate, Palo Alto
Stella Sarma
Special Counsel, Brussels
Elizabeth Skey
Partner, Palo Alto
Leo Spicer-Phelps
Associate, London
Connor Tweardy
Associate, Boston
Drew Williamson
Partner, San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Michael Young
Senior Paralegal, San Francisco
Victoria Bocek
Senior Paralegal, Boston

Related Practices & Industries

Precision Nano Sells to Danaher's Life Sciences Platform

June 2, 2021

Cooley advised Precision Nano, a developer of technologies and solutions for genetic medicines, including mRNA vaccines and therapeutics, on its sale to Danaher Corporation's life sciences platform. Danaher designs, manufactures and markets professional, medical and commercial products and services. Partner Laura Medina led the team advising Precision Nano.

Read more

Related contacts

Laura M. Medina
Partner, Colorado
Alessandra Murata
Partner, Palo Alto
Jeffrey J. Tolin
Partner, New York
Calvin Lee
Associate, New York

Related Practices & Industries

View more

Admissions and credentials

New York

District of Columbia